Thomas W. Grunt
Signaling Networks Program
Department of Medicine I
Medical University Vienna
Vienna
Austria
Name/email consistency: high
- Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells. Grunt, T.W., Wagner, R., Grusch, M., Berger, W., Singer, C.F., Marian, B., Zielinski, C.C., Lupu, R. Biochem. Biophys. Res. Commun. (2009)
- Upregulation of retinoic acid receptor-beta by the epidermal growth factor-receptor inhibitor PD153035 is not mediated by blockade of ErbB pathways. Grunt, T.W., Tomek, K., Wagner, R., Puckmair, K., Kainz, B., Rünzler, D., Gaiger, A., Köhler, G., Zielinski, C.C. J. Cell. Physiol. (2007)
- The DNA-binding epidermal growth factor-receptor inhibitor PD153035 and other DNA-intercalating cytotoxic drugs reactivate the expression of the retinoic acid receptor-beta tumor-suppressor gene in breast cancer cells. Grunt, T.W., Tomek, K., Wagner, R., Puckmair, K., Zielinski, C.C. Differentiation (2007)
- An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells. Grunt, T.W., Puckmair, K., Tomek, K., Kainz, B., Gaiger, A. Biochem. Biophys. Res. Commun. (2005)